The 28-year-old woman says she drank two and a half Charged Lemonade drinks and was in the emergency room the very next day. According to her lawsuit, she was diagnosed with atrial fibrillation and is now taking daily heart medications. 

Integer's estimated 2023 sales nearly reached $1.6 billion, up 16% compared to 2022. According to the company's statement, this acquisition helps expand its footprint in several key markets. 

The news comes as more and more medications, including Lilly's own tirzepatide, are being used to treat both obesity and diabetes. 

Private equity is becoming more and more influential in many healthcare specialties, including cardiology. This has prompted increased speculation about the impact such investments may have on patient outcomes.

To date, the company has raised $42 million to develop its transcatheter mitral valve repair system.

Yousif Ahmad, MD, spoke with Cardiovascular Business about the latest advances in IVL therapy, including new reimbursement changes for the technology. 

Congress has already adjourned for the year without taking action, but U.S. medical societies are hoping relief from significant Medicare cuts will arrive in early 2024. 

The company and one of its subsidiaries would allegedly confuse clinicians and have them bill government programs for cardiac monitoring services that were more expensive than what they needed. This settlement resolves those allegations.